---
title: "AI Infrastructure Spend Fuels Amkor and Viavi, But Logitech Warns of Supply Shocks"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294796123.md"
description: "The mid-2026 earnings cycle highlights a stark contrast between AI-driven hardware revenue surges and supply chain vulnerabilities, while geopolitical jitters keep volatility instruments highly active."
datetime: "2026-08-04T09:17:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294796123.md)
  - [en](https://longbridge.com/en/news/294796123.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294796123.md)
---

# AI Infrastructure Spend Fuels Amkor and Viavi, But Logitech Warns of Supply Shocks

The tech and AI infrastructure rollout continues to dictate cross-sector fundamentals in mid-2026, though semiconductor supply chain fragility is starting to bite. Amkor Technology (AMKL.US) highlights the hardware boom, booking USD 1.9 billion in Q2 sales and cementing a strategic partnership with NVIDIA for next-gen AI infrastructure packaging. Networking player Viavi Solutions (VIAV.US) is riding a similar wave, launching Ultra Ethernet validation for AI data centers and posting a 42.8% jump in Q3 revenue. Yet, the broader tech rally—amplified by leveraged instruments like ProShares UltraPro QQQ (MQQQ.US)—faces macroeconomic headwinds. ProShares VIX Mid-Term Futures ETF (VIXM.US) has seen heightened interest as geopolitical tensions and rate-cut speculations drive market fluctuations and prompt hedging strategies.

The hardware constraint reality is hitting consumer electronics fast. Logitech (LOGI.US) delivered a strong 2027 fiscal Q1 with a 7% sales bump, but management explicitly warned that a semiconductor supplier's factory closure will shave up to USD 200 million off its Q3 top line. Meanwhile, the software and data side remains insulated from physical bottlenecks: Moody's Corporation (MCO.US) is aggressively embedding its credit intelligence into enterprise workflows via a Microsoft Copilot partnership, raising its full-year buyback target to USD 3 billion following a 15% revenue surge in Q2.

Beyond pure tech, healthcare players are locking in key 2026 clinical and commercial milestones. Senseonics Holdings (SENS.US) reported an 87% year-over-year leap in Q1 revenue for its glucose monitoring systems, backed by a new digital app partnership with Welldoc. On the oncology front, Verastem (VSTM.US) advanced its KRAS G12D inhibitor into Phase 2 trials following an FDA fast-track designation. Conversely, other niche players face divergent operational realities: Aaron Oil Company (AAOG.US) maintains a quiet footprint in environmental services, while Rockley Photonics Holdings (RKLZ.US) navigates off-exchange liquidity constraints following its NYSE delisting.

### Related Stocks

- [LOGI.US](https://longbridge.com/en/quote/LOGI.US.md)
- [VIAV.US](https://longbridge.com/en/quote/VIAV.US.md)
- [MCO.US](https://longbridge.com/en/quote/MCO.US.md)
- [VSTM.US](https://longbridge.com/en/quote/VSTM.US.md)
- [SENS.US](https://longbridge.com/en/quote/SENS.US.md)

## Related News & Research

- [Moody's Ratings Places EasyJet's Baa2 Ratings On Review For Downgrade](https://longbridge.com/en/news/295386212.md)
- [Should Logitech’s Q1 Beat, Buybacks and Streamlabs Upgrade Require Action From Logitech (SWX:LOGN) Investors?](https://longbridge.com/en/news/295462742.md)
- [Moody's Corporation $MCO Stock Holdings Lifted by Assenagon Asset Management S.A.](https://longbridge.com/en/news/295293940.md)
- [Viavi director Joanne Solomon disposes of 10,000 shares worth $429,200](https://longbridge.com/en/news/295964703.md)
- [Viavi EVP and Chief Marketing & Strategy Officer Paul McNab sells 1,595 shares worth $59,593.15](https://longbridge.com/en/news/295535658.md)